Related Experiment Video

Updated: Aug 25, 2026

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
06:22

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

Published on: February 10, 2023

Japan's contribution to clinical pediatrics research in the last decade

Shigeru Okamoto1, Mahbubur Rahman, Tsuguya Fukui

  • 1Department of General Medicine and Clinical Epidemiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Pediatrics International : Official Journal of the Japan Pediatric Society
|March 27, 2004
PubMed

Insights

Japan

Area of Science:

  • Pediatric Research
  • Clinical Pediatrics
  • Medical Research Trends

Background:

  • Assessing global contributions to medical research is crucial for understanding scientific progress.
  • Japan's role in clinical pediatrics research requires detailed examination.

Purpose of the Study:

  • To quantify Japan's contribution to clinical pediatrics research from 1991-2000.
  • To analyze trends and the quality of evidence in Japanese pediatric research.

Main Methods:

  • MEDLINE database search for articles in top pediatrics journals (1991-2000).
  • Counted articles with Japanese institutional affiliations.
  • Analyzed proportions of randomized controlled trials (RCTs) and compared with global averages.

Main Results:

  • Japan contributed 3.0% of articles, ranking 7th globally.
  • A non-significant negative trend in Japan's contribution was observed.
  • Japanese studies had a very low proportion of RCTs (0.34%) compared to the overall average (7.3%).

Conclusions:

  • Japan's output in clinical pediatrics research is lower than in basic sciences.
  • The volume of high-evidence studies (RCTs) from Japan in pediatrics is notably limited.
Abstract

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...